Your browser doesn't support javascript.
loading
HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities.
Yang, Hongbing; Rei, Margarida; Brackenridge, Simon; Brenna, Elena; Sun, Hong; Abdulhaqq, Shaheed; Liu, Michael K P; Ma, Weiwei; Kurupati, Prathiba; Xu, Xiaoning; Cerundolo, Vincenzo; Jenkins, Edward; Davis, Simon J; Sacha, Jonah B; Früh, Klaus; Picker, Louis J; Borrow, Persephone; Gillespie, Geraldine M; McMichael, Andrew J.
Afiliación
  • Yang H; NDM Research Building, Nuffield Department of Medicine, Oxford University, Oxford OX3 7FZ, UK.
  • Rei M; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford OX3 9DS, UK.
  • Brackenridge S; NDM Research Building, Nuffield Department of Medicine, Oxford University, Oxford OX3 7FZ, UK.
  • Brenna E; NDM Research Building, Nuffield Department of Medicine, Oxford University, Oxford OX3 7FZ, UK.
  • Sun H; NDM Research Building, Nuffield Department of Medicine, Oxford University, Oxford OX3 7FZ, UK.
  • Abdulhaqq S; Key Laboratory of AIDS Immunology, Department of Laboratory Medicine, First Affiliated Hospital of China Medical University, Shenyang, China.
  • Liu MKP; Chinese Academy of Medical Sciences Oxford Institute, NDM, Oxford University, Oxford, UK.
  • Ma W; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Kurupati P; Centre For Immunology and Vaccinology, Chelsea and Westminster Hospital, Imperial College, London, UK.
  • Xu X; Centre For Immunology and Vaccinology, Chelsea and Westminster Hospital, Imperial College, London, UK.
  • Cerundolo V; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford OX3 9DS, UK.
  • Jenkins E; Centre For Immunology and Vaccinology, Chelsea and Westminster Hospital, Imperial College, London, UK.
  • Davis SJ; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford OX3 9DS, UK.
  • Sacha JB; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford OX3 9DS, UK.
  • Früh K; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, Oxford OX3 9DS, UK.
  • Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Borrow P; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Gillespie GM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • McMichael AJ; NDM Research Building, Nuffield Department of Medicine, Oxford University, Oxford OX3 7FZ, UK.
Sci Immunol ; 6(57)2021 03 25.
Article en En | MEDLINE | ID: mdl-33766848
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Infecciones por VIH / VIH-1 / Linfocitos T CD8-positivos / Productos del Gen gag del Virus de la Inmunodeficiencia Humana / Interacciones Huésped-Patógeno Límite: Humans Idioma: En Revista: Sci Immunol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Infecciones por VIH / VIH-1 / Linfocitos T CD8-positivos / Productos del Gen gag del Virus de la Inmunodeficiencia Humana / Interacciones Huésped-Patógeno Límite: Humans Idioma: En Revista: Sci Immunol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido